Summit Therapeutics (SMMT) Other Non-Current Assets (2021 - 2025)
Historic Other Non-Current Assets for Summit Therapeutics (SMMT) over the last 5 years, with Q3 2025 value amounting to $7.0 million.
- Summit Therapeutics' Other Non-Current Assets rose 27756.31% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 27756.31%. This contributed to the annual value of $2.5 million for FY2024, which is 4104.58% down from last year.
- Summit Therapeutics' Other Non-Current Assets amounted to $7.0 million in Q3 2025, which was up 27756.31% from $6.5 million recorded in Q2 2025.
- In the past 5 years, Summit Therapeutics' Other Non-Current Assets registered a high of $7.0 million during Q3 2025, and its lowest value of $140000.0 during Q3 2022.
- Its 5-year average for Other Non-Current Assets is $2.3 million, with a median of $1.9 million in 2024.
- Per our database at Business Quant, Summit Therapeutics' Other Non-Current Assets skyrocketed by 299428.57% in 2023 and then crashed by 5699.45% in 2024.
- Over the past 5 years, Summit Therapeutics' Other Non-Current Assets (Quarter) stood at $170000.0 in 2021, then skyrocketed by 239.41% to $577000.0 in 2022, then surged by 649.05% to $4.3 million in 2023, then plummeted by 41.05% to $2.5 million in 2024, then skyrocketed by 176.06% to $7.0 million in 2025.
- Its Other Non-Current Assets stands at $7.0 million for Q3 2025, versus $6.5 million for Q2 2025 and $4.1 million for Q1 2025.